|
|
||||||||
a Santa Cruz Hospital, Carnaxide, Portugal
b Heart Center, Dresden University Hospital, Dresden, Germany
c San Raffaele Hospital, Milano, Italy
d Columbia University Medical Center, New York, United States
e Valencia University General Hospital, Valencia, Spain
Received 5 September 2007; received in revised form 20 December 2007; accepted 21 December 2007.
* Corresponding author. Tel.: +351 210433160; fax: +351 210433159. (Email: joaomelo100{at}hotmail.com).
| Abstract |
|---|
|
|
|---|
Key Words: Atrial fibrillation Ablation Pacemaker
| 1. Introduction |
|---|
|
|
|---|
| 2. Materials and methods |
|---|
|
|
|---|
All patients had a previous pacemaker implanted for bradyarrhythmia. Fifteen patients were taking class I or III antiarrhythmic agents. Three patients had undergone unsuccessful cardioversions. Three patients had a history of systemic embolism and two patients have been submitted to percutaneous ablation or atrial fibrillation.
The most significant clinical characteristics of the group are described in Table 1 .
|
The main operative procedures are described in Table 2 . Fifteen patients had multiple operative procedures.
|
Ablation methods were performed according to surgeons choice. Energies used were either microwave (24 patients), or radio frequency (RF). Unipolar RF in 10 and bipolar in two patients.
The ablation procedures were biatrial in seven patients, left atrial in 27 patients, and right atrial in two patients. One patient had a maze III procedure.
Different ablation patterns are described in Table 3 .
|
All patients received anticoagulation therapy under a protocol with coumadin for a period of at least 3 months after surgery to attain INR values between 2.0 and 3.5. Patients with prostheses were kept under anticoagulation therapy. Class I and III antiarrhythmic agents were used selectively in patients who had postoperative AF with rapid ventricular response.
After hospital discharge, patients were evaluated at 1, 6, 12 and 24 months after surgery. Rhythm was described on the basis of surface EKG.
2.2 Statistical analysis
Continuous data are expressed as mean and standard deviation or median and IQ range in the case of non-normally distributed data. Comparison between groups was made using Fisher's exact test for categorical data and t-test for continuous data. Non-normally distributed data were compared using the Wilcoxon rank sum test.
| 3. Results |
|---|
|
|
|---|
Follow-up varies from 3 to 26 months. Median follow-up was 18 months (range 3–26). During follow-up there were no deaths or embolic events. There were no device-related complications.
Table 4 describes heart rhythm of the 33 survivors at various points in time during follow-up.
|
|
| 4. Discussion |
|---|
|
|
|---|
The analysis of our group of patients was surprising because of the unexpected high number of patients that recovered sinus rhythm. In fact, two thirds of our patients have regained sinus rhythm at 1 year, and of these only 14% were pacing dependent. These results are similar to the ones reported previously from the Registry in 1723 mitral patients [2]. Interestingly the results were similar in the various institutions participating in the study.
We have searched for predictors of sinus rhythm recovery at 1 year. Because of the uncertainties of the clinical consequences for patients that recovered sinus rhythm but were still bradycardic and pacing dependent, we included these patients in the same group of those remaining in atrial fibrillation. With this assumption we have created the worst-case scenario that may have contributed for not finding predictors of success with statistical significance. Yet patients that have small left atria and those with paroxysmal or persistent atrial fibrillation have better recovery as expected from the experience of treating patients with atrial fibrillation and not pacing dependent [3,4].
The groups of patients that recovered sinus rhythm and were still pacing dependent are a very puzzling group. It is important to know if they will benefit from treating atrial fibrillation. Is it logical to assume that by using physiological pacing they will have a similar outcome to the patients who recovered sinus rhythm? Only with larger experience will this knowledge become available.
Because of the small sample size it is not appropriate to draw definitive conclusions from this study but it appears very promising given the lack of late complications.
One major limitation of our study is the lack of Holter monitoring as a more precise tool to define patients rhythm.
Also it is very important for the future to establish if the long-term benefit of this approach will be sustained.
The question remains if it is reasonable/useful for patients with a history of AF and pacing-dependent bradycardia to ablate atrial fibrillation when they are submitted to a concomitant procedure.
Our results are very encouraging, but deserve further evaluation.
In the meantime it appears that patients with permanent atrial fibrillation who will benefit more from the procedure are those with small left atria. Also if patients have paroxysmal or persistent atrial fibrillation and are submitted to ablation the results will likely be better.
We conclude that in a significant number of patients the presence of a pacemaker before surgery does not preclude sinus rhythm recovery after cardiac surgery and ablation for concomitant atrial fibrillation.
| Appendix A |
|---|
|
|
|---|
Dr J. Bonatti (Innsbruck, Austria): The question that the multicenter study group asks in this paper is unique and the results are highly interesting for the heart surgery community. Few patients, however, are affected by the problem which the group addresses. It is 1.6% of the patients in your large database of more than 2000 people.
The main strength of the study is that it was derived from a large multicenter registry which was established by surgeons with extensive experience in surgical electrophysiology. The fact that different energy sources were used, that procedure conduct was inhomogeneous, and that ablation therapy was carried out in a variety of open heart procedures hampers results to a certain extent, and future studies should look at more homogeneous patient cohorts.
Whether surface ECGs taken at 1, 6, 12 and 24 months postop are enough to assess the real percentage of patients in sinus rhythm can be discussed. You mention this yourself in the paper. In addition, one has to be aware of the fact that a significant number of patients regained sinus rhythm but required pacing for bradycardia. At 24 month there was a trend towards more patients in A-fib and less patients in pacing-dependent sinus rhythm. An intense look at long-term follow-up is definitely necessary. Results concerning prediction of sinus rhythm recovery in your study are plausible. I have three questions.
Is there any paper showing similar results after catheter-based ablation in A-fib in patients with previous pacemaker implantation? Second, was pacemaker explantation in some patients discussed or even carried out? And third, what was the impact of procedure success on medical treatment of the patients?
Dr Melo: Of course when we started looking at this issue, we were aware that this is a rare condition. We performed extensive search in the literature and could not find any previous reports on this topic, and that is why we decided to analyze it.
Out of these 36 patients, we are aware of two patients where the pacemakers were explanted for local reasons, and one of the patients demanded it because it was bothering him, and it was explanted. I have data showing that he really was not pacing dependent. But I think at this moment and at this point of knowledge, if the pacemaker is there, it should be kept in place, because this papers shows that it is possible to lose sinus rhythm. Of course, this is a basic question, and with such small sample we cannot go much further. Our conclusion is that it is possible to regain sinus rhythm, especially if patients have small atria.
Regarding your last question, impact of medication of those patients, I cannot tell you. We dont have that data in our database.
| Acknowledgments |
|---|
| Footnotes |
|---|
Presented at the 21st Annual Meeting of the European Association for Cardio-thoracic Surgery, Geneva, Switzerland, September 16–19, 2007. | References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |